Enanta Pharmaceuticals (ENTA) Tax Rate (2014 - 2026)
Enanta Pharmaceuticals' (ENTA) quarterly Tax Rate came in at 0.05% in Q1 2026, down 550.0% YoY from 0.01% in Q1 2025, and up 73.44% on a QoQ basis from 0.2% in Q4 2025.
Enanta Pharmaceuticals (ENTA) Tax Rate (2014 - 2026) Analysis & Trends
Enanta Pharmaceuticals (ENTA) has 13 years of Tax Rate data on file, last reported at 0.05% in Q1 2026.
- Quarterly Tax Rate fell 550.0% year-over-year to 0.05% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.15% (down 266.0% YoY) and the FY2025 annual result came in at 1.99%, up 51.0% from the prior year.
- Tax Rate improved to 0.05% in Q1 2026, from 0.2% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 13.32% in Q3 2023 to a low of 12.11% in Q2 2023.
- A 5-year average of 0.95% and a median of 0.63% in 2022 frame the typical range for Tax Rate.
- The widest YoY moves for Tax Rate: up 14521 bps in 2022, down 2670 bps in 2022.
- Tracing ENTA's Tax Rate over 5 years: stood at 0.12% in 2022, then surged by 1460 bps to 1.83% in 2023, then gained by 0 bps to 1.83% in 2024, then sank by 111 bps to 0.2% in 2025, then surged by 73 bps to 0.05% in 2026.
- The last three Tax Rate figures came in at 0.05% (Q1 2026), 0.2% (Q4 2025), and 0.17% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Enanta Pharmaceuticals | 383.29 Mn | 193.78 Mn | - | -0.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18% |
| Jun 30, 2026 | -0.18% |
| Jun 30, 2026 | -0.18% |
| Mar 31, 2026 | -0.05% |
| Mar 31, 2026 | -0.05% |
| Mar 31, 2026 | -0.05% |
| Dec 31, 2025 | -0.20% |
| Dec 31, 2025 | -0.20% |
| Dec 31, 2025 | -0.20% |
| Sep 30, 2025 | -0.17% |
| Sep 30, 2025 | -0.17% |
| Sep 30, 2025 | -0.17% |
| Jun 30, 2025 | -0.16% |
| Jun 30, 2025 | -0.16% |
| Jun 30, 2025 | -0.16% |
| Mar 31, 2025 | 5.45% |
| Mar 31, 2025 | 5.45% |
| Mar 31, 2025 | 5.45% |
| Dec 31, 2024 | 1.83% |
| Dec 31, 2024 | 1.83% |